PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNT
Registered number: 01635916
Charity number: 284881
PENNY BROHN CANCER CARE
TRUSTEES. REPORT AND
FINANCIAL STATEMENTS FOR
THE YEAR ENDED
30 NOVEMBER 2024

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNT
CONTENTS
PAGE
Reference and Administrative Details of the Charity, its Trustees and Advisers
Independent Auditor's Report on the Financial Statements
19
Consolidated Statement of Financial Activities
22
Charity Statement of Financial Activities
23
Charity and Consolidated Balance Sheet
24
Consolidated Statement of Cash Flows
25
Notes lo the Financial Statements
26

PENNY BROHN CANCER CARE
ANNUAL REPORT AND ACCOUNTS
REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES
ANDADVISERS
Trustees
Amanda Hill.,.
Bina Shah 2&4
Bronwen Wright, (appointed 10.05.2024}
Charles Russell-smilh
Charlotte While
(resigned 12.07.20241
Emma Wallis'°.' (appointed 10.05.20241
Harvey Marcus." . lappoinled 10.05.20241
Jacqueline Graves '
Jayne Tucker,
Jessica Brohn
Jonathan Green '
Kate Pavli
Nicola Newton
Stephen Rosser,
' {appointed 10.05.2024}
2È4
Sub<ommittees
Finance and Audit Committee,
2. People, Culture and Inclusion Committee.
3. Commercial Committee
4. Services Committee
5. Fundraising and Marketing Committee
Company Registered Number
01635916
Charlty Reglstered Number
284881
Registered Office
Chapel Pill Lane, Pill, Bristol, BS20 OHH
Company Secretary
Lisa Day Iresigned 16.05.20251
Eleanor Davies {appoinled 16.05.20251
Chief Executive Officer
Andrew Hufford
Independent Auditors
Burton Sweet Limited
The Clock Tower
5 Farleigh Court
Old Weston Road
Flax Bourton
Bristol BS48 1 UR
"We need more than medicine to live well with cancer.
We need to care for our mind, emotions. spirit, heart and soul."
Penny Brohn. 1980

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNT
Chair's Foreword
It is my privilege lo introduce Penny Brohn Cancer Care's Annual Report for 2024.. a year shaped by
renewed clarity, growing impact, and deepened commitment lo those we serve.
Over the past year, Penny Brohn Cancer Care supported 4,989 individuals through our National Cenlre,
online services, and partnership with Genesiscare. Of ihese, 2,137 accessed our in-person and online
ServI￿S directly la 9°/0 increase on the previous yearl and we saw a 30 /0 rise in new client registrations.
This reflects growing demand for personalised cancer care and the trust placed in us by our community.
As the UK'S leading provider of personalised cancer care. we delivered compassionate support across
a wide range of needs via our National Centre, digital, and community services.
A key part of our reach came through our partnership with Genesiscare. As the lead provider of
personalised support in their cenlres, Penny Brohn Cancer Care delivered over 9.700 appointments to
people undergoing treatment, extending our model of care to thousands more across the UK. This
collaboration refleds the strength of our approach and the power of partnership lo reach people when
Ihey need us most.
Like many charities, we faced financial pressures in 2024 bul responded with determination and focus.
We grew commercial income, increased retail turnover, expanded venue hire, and continued to diversify
revenue, demonslraling resilience and long-term ambition.
As this report shows, 2024 was a year of slabilisalion and progress. We introduced new services like
Personal Planning and Connect. strengthened our counselling and menopause support, and secured
national accreditation for our health information. We improved referral pathways and laid foundations
for a new online prehabililation service. In all of this, we kept evolving, making meaningful strides
towards a more responsive and resilient future while staying true to OLJr aim of helping people feel more
in control of their health and wellbeing during cancer.
Looking ahead, we are sharpening our strategy and strengthening our identity. With a refreshed
leadership team in place, we are focused on embedding Penny Brohn Cancer Care as a nationally
respected, proudly Bristol-based brand-rooted in place, purpose. and the power of compassionate
care.
On behalf of the Board of Trustees, thank you to everyone who made this year possible. From our staff
and volunteers to our supporters and partners.. your dedication continues to inspire. Together, we are
building something lasting.
Stephen Rosser
Chair of Trustees

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNT
Our Transfomiational Services
In 2024, Penny Brohn Cancer Care set ambitious goals to expand our support services and reach more
individuals affected by cancer, ensuring they have access lo the care they need to live well, regardless
of their prognosis. Throughout the year, significant progress was made in increasing both the number
of people supported and the breadth of services available.
A key highlight was the 9°/0 increase in total clients, bringing the total number of individuals accessing
in-person and group support to 2,137. Particularly encouraging was the 300/0 rise in new registrations,
demonstrating that our outreach initiatives are successfully connecting with those in need. These efforts
focused on making our services more accessible, relatable, and relevant, particularly through NHS and
Macmillan referrals and targeted engagement with cancer support groups.
Enhancing Accessibility and Diversity
A major priority in 2024 was expanding access lo a more diverse range of people with cancer. While
progress was made in engaging a broader audience, certain challenges remained. Efforts lo reach more
men with our services were slower than anticipated, but valuable insights were gained that will inform
future approaches. Similarly, our efforts lo support people from a wider range of socio-economic
backgrounds saw mixed results. The proportion of clients from the least deprived areas (deciles 8-101
remained al 470/., the same as in 2020, while 120/0 of users came from the most deprived areas (deciles
1-31.
Efforts lo improve ethnic diversity were also a focus, although data collection remains incomplete. Early
indications suggest that 790/0 of new clients identified as While British (compared to the UK average of
700/91, while 89,/0 identified as White, representing a decrease from 930/0 in 2020. While these results
show progress, increasing accessibility and engagement across diverse communities will remain a core
priority in 2025 and beyond.
Client Voice and Co-Production
The Client Voice Group grew significantly in 2024, reaching 40 members-24 of whom joined this year.
Clients have helped shape new services, including offerings for men and online resources. Two Client
Voice newsletters were published by our volunteer Client Voice Lead and shared with our wider
supporter base. Embedding client voice into service development remains a core principle of our
approach.
Tailored Support for Key Can¢er-Related Concerns
Recognising that people with cancer share common holistic support needs, such as managing fatigue,
anxiety, insomnia, and hormonal changes, we tailored our services to focus on practical, accessible
solutions. This approach ensures our services remain both effective and widely beneficial, while also
allowing for personalised pathway navigation for those with more specific needs.
Several tsrgeled service packages were introduced in 2024..
Menopause Support: Following a successful pilot in 2023 with Genesiscare patients, we
rolled out four online multi-expert group sessions, allended by 104 participants, and introduced
a new Menopause Wellbeing Day. which saw 55 in-person allendees.
Psychological Support: We expanded our counselling services with the launch of the Mind
Matters Wellbeing Day, attracting 31 bookings and 25 allendees. Additionally, we introdu¢ed
Connect, a series of counsellor-led emotional support groups tailored for both general cancer
patients and those with advanced diagnoses. Although attendance was lower than expected
Ilypically 3-6 participants per session), the service has been highly valued. and a full review is
planned for 2025.

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNTS
Personal Planning Seniice: This one-to-one navigation support was introduced in May 2024,
offering 88 appointments. Feedback was overwhelmingly positive, with clients booking belween
2 and 10 follow-up services. One client remarked, "Just so in¢￿dible - Gombining professional
and knowledgeable with empathy and support. Thank you.. Since launch, 1000/0 of Personal
Planning clients have said the service helped them understand how Penny Brohn Cancer
Care55 can support them.
Evaluating Expanded In-Person Services
With the generous support of Walk the Walk Worldwide, we were able lo expand our in-person services,
providing a safe and uplifting environment for individLJals affected by cancer. In 2024, 417 people
attended 12 themed Wellbeing Days and seven residential Living Well Retreats al our Bristol cenlre.
Among these new offerings, our Mind Matters and Menopause Support Wellbeing Days proved
particularly popular, attracting high levels of interest and being overbooked in some cases. Conversely,
our efforts lo engage more men with our services through Men's Recharge Days proved more
challenging, with lower attendance than anticipated. However, client feedback on these new Wellbeing
Days was overwhelmingly positive, with an average satisfaction rating of 4.7 out of 5 across all sessions,
reinforcing the need lo refine and develop these offerings over time.
One participant from the Recharge Day for Men said, "Overall fantastic. Has tmly, positively chsnged
the direction of my cancer journey for the better." Another attending the Menopause Wellbeing Day
remarked, "A goodmix of theory andpractical experiences. Excellent lunch. I definilelyfeel topped up.
Feedback from the Mind Matters Wellbeing Day was similarfy strong.. "Really lovelyday. Lols of content.
Really enjoyed meeting people...
Our Residential Retreats also maintained high satisfaction scores, with allendees rating the overall
experience al 4.8 out of 5. One participant shared, -This retreat has saved my lrfe. All my emotional,
spiritual andphysical needs have been met.. I will go home nurtur6d, restored and energised."
Expanding and Evaluating Hybrid 1-1 and Group Services
In 2024, we continued lo build our online services programme. offering over 20 live groups including
Nutrition Know How, Yoga, Clinical Hypnotherapy, Lymphoedema Support, Menopause Support, and
Connect (group counsellingl. A rolling ev8lu8tion programme, using follow-up surveys and validated
prelpost measures, has consistently shown high satisfaction and pos((ive outcomes. In a 2024 survey,
750/y of respondents said the number of services was "about right,. and 730/0 rated the content as very
helpful.. Ninety-five Per￿nt said they would recommend our online services lo others.
Clients highlighted the accessibility of online services.. "I was very grateful to use this when I was al my
lowest ebb in hospital.. the infom7ation and follow-ups wer8 so valuable."Anolher said, "Fatigue is a
real Issu￿]01n1n9 groups online meant I could still participate while resting in bgd."
Evaluation of our flagship online Treatment Support Programme showed a 4.8 out of 5 average
satisfaction score. Eighly-one percent of participants said il helped them feel more confident about
getting through treatment, and 1 OOOA said they would recommend it. One client reflected, °From the first
session, I fell like I'd been gentlypicked up from the floorandsetstraight again... l am incrediblygrateful
to have found Penny Brohn when I did.~
Our other one-trFone servi￿8 also continued lo achieve strong OLJtcomes. In 2024, 95 /0 of doctor one-
to-one clients felt supported and listened to, and 98°/o said they would recommend the service. Among
clients receiving nutritional therapy, 94 % fell empowered lo make informed choices, and 97.10 reported
a better understanding of their dietary needs. One client noted, "I came away feeling like a person again
rather than a cancerpatl8nt... I feel so empowered by the support I havg received from Penny BrohTr-
8nd yes, there are things I can do to keep myself well."

PENNY BROHN CANCER CARE
ANNUAL REPORT AND ACCOUNT
Prehabilitation and Symptom Management
Understanding the importance of preparing individuals for cancer treatment, we began work on a
prehabililalion service pilot towards the end of 2024. This initiative, led by our Physical Activity and
Clinical Leads, in collaboration with our Nutrition Lead and oncology teams from the Bristol, North
Somerset, and Gloucester IBNSSGI Integrative Care Board, is sel to launch in May 2025. The new
Servi￿ will provide a slruclured support package for individuals awaiting cancer treatment, helping
them build resilience and improve outcomes.
Additionally, we broadened our support for key physical and emotional side effects of cancer treatment,
including expanding services for psychological support, menopause-related symptoms, lymphoedema,
and scar concerns.
Improving Infomiation Accessibility
As part of our commitment lo providing high-qualily, evidence-based information, Penny Brohn Cancer
Care a¢hieved Patient Information Forum IPIF Tickl a¢creditation in May 2024. This recognition
underswred the trustworthiness and reliability of our health information. We have since launched
rigorously reviewed resources.. Eating WellDuring Cancer Treatment and Eating When Eating Becomes
Difficutt.
Strengthening Healthcare Referrals and Outreach
In 2024, Penny Brohn Cancer Care made significant strides in raising awareness and increasing
referrals from healthcare professionals, cancer support charities, and patient groups. A particular
highlight was our attendance al the Oncology Professional Care conference in May 2024. where our
Lead Doctor, Dr Catherine Zollman showcased our Treatment Support Programme. This event
generated substantial interest among Clinical Nurse Specialists in our integrative cancer care approach.
Our outreach efforts have also translated into tangible improvements in referrals. 22 /0 of new clients
were referred by their cancer nurse specialist in 2024, a marked increase from previous years.
Additionally, 120/0 of new clients found us through Macmillan referrals, further reinforcing our growing
visibility wf(hin the healthcare sector.
In response lo community needs, we also expanded the range of support available in the Bristol area,
introducing Nordic Walking groups, creative therapy sessions, a Community Kitchen for cooking
demonstrations, a Nutrition Café, and Tea & Chal sessions. Additionally, we launched weekly massage
and reflexology appointments at our Hub in the Bristol Triangle, providing further holistic support lo
those undergoing treatment.
Partnership with Genesiscare
Penny Brohn Cancer Care's long-standing partnership with Genesiscare remained a cornerstone of
our mission to deliver holistic, pers0n-￿ntred ¢an¢er Care. Now in its lenlh year, the collaboration
¢onlinu8s lo provide vital holistic support to P8opI8 receiving treatment al Genesiscare c8nlr8s across
Ihe UK.
Be￿een December 2023 and November 2024, the partnership supported 2,849 patients, delivering
over 9,700 appointments. Initial consullalions included 1,979 holistic needs assessments, 303
wellbeing appointments, and 68 palliative reviews. Following these, a wide range of therapies and
support were delivered, including 2,689 sessions of reflexology, 716 of acupuncture, 718 counselling
sessions, and 640 lifestyle support consultations. Clients also accessed 1,271 relaxation and
mindfulness sessions, 81 relative support sessions, and 1,105 end-of-treatment reviews.
Although overall patient numbers saw a small decrease of 6D/o compared to the previous year, this was
attributed to temporary service changes due to staff sickness, vacancies, and the refurbishment of bmo
Genesiscare centres. Despite this, the Servi￿ continued lo deliver exceptional support, with patients

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNT
1963 male and 1,886 female) accessing care across a wide range of needs. Breast cancer remained
the most common diagnosis, with 1,226 patients receiving support.
Feedback from patients has been overwhelmingly positive..
"Penny Brohn gives vrfal support al a difficult lime when there is nothing else in the medical trealmenl
structure lo help.
"I'm so bloody glad I came here, one of the best decisions I made... I'm coming out of this positivel~
In the latest Patient Experi8nc8 IPREMI data sel, 88Q/o of respondents In=4041 said the service made
a positive difference lo their hea￿h and wellbeing. The PROM data showed a 77QA clinically significant
improvement in patients, primary concern.
Continuous improvement was a key feature of the service throughout 2024. Developments included
refining the induction and training process for new staff, strengthening remote counselling provision,
and enhancing communication within the delivery team through weekly updates and monthly
collaboration meetings. One key change was the recruitment of a core-hours counsellor to provide
greater slabilty within the counselling team.
In addition lo the clinical and wellbeing impact, the partnership also generated £13,799 through
fundraising activities across the Genesiscare nehNork.
To mark ten years of partnership, we created an infographic celebrating a decade of impact, featuring
cumulative attendance and outcomes data. This was shared with Genesiscare colleagues and
displayed in each cenlre.
Brand and Marketing
In 2024, Penny Brohn Cancer Care focused on strengthening our internal identity and external
communications. A major strand of this work was the development of new organisational values. The
process began in late 2023 with a staff workshop introducing the concept of values and exploring
examples from across the sector. Staff worked in groups to reflect on what the charity s values should
be, feeding back suggestions which were then reviewed and refined into a proposed sel.
These proposed values were reviewed by the Senior Leadership Team and formally approved by the
Board of Trustees in February 2024. A follow-up session in March reinlrcKluced the values lo staff,
providing context for the work and encouraging teams lo reflect on how the values align with their own
objectives and aspirations.
The year also saw the launch of the Ham Green House webstte and social media channels (Facebook,
Inslagram, and Linkedlnl, expanding the venue's reach and visibility. A new monthly newsletter for
healthcare professionals was introduced, which grew to a subscriber base of around 160 contacts.
The charity produced ils first-ever client case study video. capturing a powerful story lo help
communicate the impact of its services. It also Irialled two Instagram Live sessions in collaboration with
expert practitioners from partner organisations.
Email marketing continued to grow, with the weekly services newsletter reaching an average of 700
more recipients compared to the previous year.
Financial Sustainability
Following the financial challenges of 2022, we embarked on a five-year financial recovery plan designed
lo restore stability and build long-lerm sustainability. We have just completed th8 second year of that
plan.

PENNY BROHN CANCER CARE
ANNUAL REPORT AND ACCOUNT
Year one of the plan Ilhe 2022123 financial yearl delivered a better-than-expected outcome, thanks in
part to a combination of one-off legacies, the success of our Emergency Appeal, and significant growth
in our hospitality income. These factors resulted in a nel surplus of £94,734-an encouraging early slep
in our recovery journey.
In the current financial year120231241, we concluded the year with a nel deficit of £336,310. This was
primarily driven by underperformance in legacy income, coupled with slower-lhan-anticipaled
momentum in our wider fundraising activity. In addition, while hospilalily income remained strong, il
plateaued after the significant growth seen in the previous year and therefore did not offset shortfalls in
other areas.
While this year's financial result represents a setback, fluctuations are lo be expected and must be
viewed in the broader context of our five-year recovery strategy. OLJf CLJrrent position, while in deficit,
does not significantly deviate from the overall trajectory of the plan. We remain confident in our long-
term strategy and are actively working to regain momentum in 2025 and 2026, with early indicators
suggesting that this is achievable.
The five-year plan continues lo provide a strong framework forfinancial decision-making, and we remain
committed to disciplined financial management, strategic income diversification, and sustsinable growth
across all areas of the charity.
Income Generation
In 2024, we were able to underpin our fundraising efforts with a diverse range of initiatives helping to
secure essential income to support our seNices.
Kicking off the new financial year, December 2023 saw our most successful Christmas Concert yet,
raising £7,500 and welcoming over 400 guests for a festive evening of mLJSiC and celebration.
We were privileged lo partner with Bailey of Bristol, who selected Penny Brohn Cancer Care as their
Charity partner for 2024. Through a variety of creative fundraising initiatives, they raised an outstanding
£16,167, significantly exceeding their original fundraising largel of £1,000.
Another key partnership in 2024 was with the Bristol Property Agents Association IBPAA}, which raised
over £20,000-funds expected lo be received in summer 2025.
We were also honoured to be named Bristol Breakfast Rolary's Charity of the Year by Bernd Langheim,
President of the Bristol Breakfast Rotary, which led to our selection as the main beneficiary of the Bristol
Dragon Boat Race Festival 2024. Corporate teams took lo the waters of Bristol, securing sponsorships
and rallying behind our cause. As a result, we received almost £9,000 from the event, and we are
immensely grateful for their generosity and continued support.
One of the year's key fundraising achievements was the launch of Penny Brohn Cancer Care's first-
ever summer raffle in July and August 2024, which raised over £4,300. Our Autumn Matched Funding
Appeal proved lo be another fundraising highlight, reaching an impressive lolal of £36,000 thanks to
Ihe generosity of our donors and matched conlribulions.
We also secured significant funding through grants and charitable foundations lo support our vital work.
Notable support included..
Continued major backing from Walk the Walk Worfdwide, a key supporter of our work.
A grant from the Tim Tiley Bursary Fund to help sustain our online servi¢es.
A grant from the Gerald Micklem Charitable Trust lo support our nutrition programme.
Ongoing annual support from the Medlock Charitable Trust. this time to resource our digital
support groups.
Funding from the Screwfix Foundation to carry out essential repairs to the roof in our garden
room.

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNT
These income generation successes were instrumental in allowing us to continue providing life-
changing services to those affected by cancer. We remain incredibly grateful lo all our corporate
partners, individual donors, granl-giving organisations, and community fundraisers who have supported
Penny Brohn Cancer Care throughout 2024.
The National Centre al Ham Green House continued lo thrive as a Health & Wellness community,
reinforcing its role as both a sanctuary for cancer clients and a dynamic space for like-minded
organisalions. In addition to being a safe and tranquil haven for those affected by cancer, the National
Centre has become a sought-after venue for away days, team-building events, and workshops,
attracting a diverse range of synergistic groups and organisations.
Operating seven days a week, the Hospitality team worked tirelessly to accommodate independerbt
residential events and relreals, with most weekends fully booked throughout the year. This demand has
resulted in a significant income stream of £500,000+ per year-encompassing sublets. extemal
bookings, and ad hoc therapist sessions-and is now successfully covering the core operating costs of
Ihe National Cenlre, in line with our strategic aim.
To further enhance accessibility and visibility, Ham Green House now has its own venue hire website,
allowing potential clients to explore the National Centre's offerings with ease. Since our last report, we
have welcomed several new tenants, including Feel Better Bristol, specialists in Myofascial Release,
and a Somatic Experiencing Iherapisl. These new additions complement our existing tenants, which
include National Centre for Integrative Medicine INCIMI, SWEDA, Holistic Wellbeing, and several
individual Iherapisls.
The National Centre's largest external customer remained Internal Family Systems UK IIFSI, a
renowned therapy training organisalion. Additionally, we frequently hosted NHS departments for team
and training days, further strengthening our connections within the healthcare sector.
Beyond the financial impact, the increased activity at the National Centre has raised awareness of
Penny Brohn Cancer Care's mission, introduced new audiences to our work, and fostered potential
future ambassadors and donors. By blending financial sustainability with our core purpose, Ham Green
House continues to be an invaluable asset lo the charity-
As part of our long-lem financial recovery plan, we granted a long lease on a portion of land adjacent
to our National Centre to Natural Academy, a Bristol-based organisation that delivers nature-based and
inlegralive training programmes in mental health, wellbeing, and leadership. This partnership not only
contributes lo our income diversification and enhances our long-lerm sustsinability, but also represents
another example of a tenancy agreement with a values-aligned organisation whose mission resonates
strongly with Penny Brohn Cancer Care's holistic approach lo health and wellbeing.
The Hub - our charity shop and wellbeing space in Clifton, Bristol
continued to grow and thrive,
achieving a record turnover in 2024. This upward trajectory reaffirms its value not only as a key source
of potential unrestricted income bul also as 8 vital presence for Penny Brohn Cancer Care in the heart
of the city where our roots began. Recognising this potential, we committed to extending the lease until
2030 (with no rent increase), ensuring we give the original concept- disrLJPted in its early years by the
COVID-19 pandemic- the time il deserves to prove its impact.
Beyond retail, the Hub is embedding itself further into the community. hosting events such as book
signings with authors whose work aligns with our Whole Life Approach and Commitment lo diversity.
Importantly, this year also saw the return of cancer clients to the Irealmenl rooms al the back of the Hub
a significant slep towards realising our vision ofa space where income from the shop directly supports
wellbeing ServI￿S on-site.
10

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNT
Looking Ahead to 2025
Building on the achievements of 2024, Penny 8rohn Cancer Care remains committed to sustaining and
enhancing our impact across all areas of the organisation. While the financial lands￿pe continues lo
present challenges, our focus for 2025 is on maintaining service quality, improving infraslruclure, and
laying the foundations for future growth. Our key priorities for the year ahead include..
Developing a clarified organisational strategy, co-led by the CEO, Head of Services, and Head
of Fundraising and Communications. This strategic framework will guide the charity beyond its
recent survival phase and onto a trajectory of stability and growth.
Strengthening our fundraising capacity through the development of a new Fundraising and
Communications Strategy, led by our newly appointed Head of Fundraising and
Communications. This strategy will align with broader organisational goals and ensure long-
term income sustainability.
Expanding one-to-one counselling services lo reduce waiting times and meet increasing
demand.
Launching our online prehabililation service, supporting individuals ahead of cancer treatment
with accessible and tailored care.
Updating our Health and Wellbeing Wheel, enhancing how clients identify and navigate the
support most relevant lo them.
Continuing our partnership with Genesiscare. with ongoing discussions underway to extend
our service delivery agreement and build on ten years of successful collaboration.
Growing our hospitslity business, with strong forward bookings already secured and ongoing
discussions wfch two shared-purpose organisalions that may join our health and wellness
community as new tenants.
Enhancing our hospitality infrastructure, including the release and repurposing of additional
space within the National Centre for commercial use. Work is currently being scoped and
phased, with the first new operational rooms expected to be ready by April 2025.
Exploring the potential lo grant a further lease on land adjacent lo our National Centre, building
on previous arrangements as part of our strategy to diversify income and strengthen long-lerm
financial sustainability.
Implementing a new datsbase platform Ixviewl to streamline operations and improve servi
Coordination, accessibility, and efficiency across both Services and Hospilalily.
Expanding our volunteer engagement, with plans to bring on a volunteer lo support a review of
internal documentation and processes, ensuring they align with current gocKI practice. In
addition, Services has begun recruiting professional volunteers lo contribute their expertise and
enhance delivery.
As we move into 2025, our unwavering focus remains on ensuring that every individual facing cancer
has access to the support they need to live well, while continuing to build a resilient, forward-looking
organisalion.
THANK YOU.. To everyone who trusts us lo be part of their journey, sharing their experiences and
inspiring us every day we are truly grateful.
To Walk the Walk Worldwide, for 25 years of unwavering support. Your funding partnership
continues to power our services and our mission.
To the Tim Tiley Bursary Fund, the Gerald Micklem Charitable Trust, and the Medlock Charitable
Trust, whose loyal and generous support over many years has qLJielly bul powerfully helped
sustain our resilience and underpin our progress.
To Genesiscare, for ten years of partnership, collaboration, and shared commitment to person-
cenlred cancer care. Your support helps us reach thousands of people with the compassionate,
integrative care they deserve.

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNTS
To Internal Family Systems UK, for their long-standing partnership and continued presence al
the National Cenlre. Their support goes beyond room bookings-they've become true
ambassadors for our work.
To Cloud & More, for their generous donation of networking hardware, improving the reliability
of phone and video communications for our counsellors and therapists.
To Invictus Mechanical and the Warriors of Warmth, along with Straight Up Scaffolding, Hawk
Installation, and BBS Plumbing and Heating Supplies, for wming together lo deliver a vital
boiler replacement project, largely free of charge.
To Clarke Willmotl, for providing pro bono leg81 support during our18nd transaction and the
renewal of our lease on the Hub.
We would additionally like to thank-
The Screwfix Foundation, The Albert Hunt Trust, The Elizabeth And Prince Zaiger Trust, The February
Foundation, The D'oyly Carte Charitable Trust, J and M Britton Charitable Trust, The Joyce Fletcher
Charitable Trust, Abbvie UK, The Beaverbrook Foundation, The Frank Litchfield General Charitable
Trust, The Hilary Awdry Charitsble Trust, The Lawson Trust, Axentis Michael Charitable Trust, The
Waller Guinness Charitsble Trust, Maclaggart Third Fund, Lillie Johnson Charitable Trust, Mazars
Charitable Trust, Nisbets in the Community, Renishaw Charities Committee, The Helianthus Charitable
Trust, VWV Charitable Trust, The Gilander Foundation, The Ruth and Stuart Lipton Charitable Trust,
Quartet Communtty Foundation, and Leanne & Winston Newman Charitable Trust.
STRUCTURE. GOVERNANCE AND MANAGEMENT
Penny Brohn Cancer Care is a registered charity trading as Penny Brohn UK and is also legally
constituted as a company limited by guarantee. Established on 17 May 1982, the charity is governed
by its Memorandum and Arbcles of Association, which define its purpose, slruclure, and operational
framework.
Govemance
Penny Brohn Cancer Care is overseen by a Board of Trustees, whose primary role is to define the
Charity's vision, strategy, and objectives in alignment with its charitable purpose. The Board is
responsible for ensuring that the charity's financial resources are managed effectively and that all
activities are conducted in a manner consistent with ils mission. In 2024, the Board convened four times
in person and three limes remotely lo review progress and guide the organisation.
To maintain comprehensive oversight, the Board operates through five dedicated sub-committees, each
focusing on a core aspect of the charity.. Finance & Audit, Services, People, Culture & Inclusion,
Fundraising & Marketing, and Commercial. These committees meet remotely. ensuring agile
governance. In 2024, the Finance & Audit Committee mel six limes,. the Services Committee,
Fundraising & Marketing Committee, and Commercial Committee each mel four times,. and the People,
Culture & Inclusion Committee met three times.
Trustee Appointment. Induction. and Training
Trustees are appointed based on the skills and expertise required for strong governance al Penny Brohn
Cancer Care. A formal recruilmenl process is in place to identify suitable candidates, ensuring they
align with the organisalion's needs and values. Once appointed, each Trustee undergoes a
comprehensive induction and training process, tailored to their individual background and experience.
This includes access to key documents, a guided lour of the National Cenlre, introductions to the Chair,
Executive Team, and key staff, and an overview of the roles, responsibilities, and obligations of being a
Trustee.
12

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNTS
Trustees are encouraged lo participate in internal and external development opportunities that enhance
their ability lo fulfil their governance role effectively. A Trustee's term of office lasts three years, with the
option lo serve up lo three consecutive terms. Extensions beyond this period are only granted in
exceptional circumstances. All Trustees volunleer their lime and re￿1ve no financial compensation or
benefits from the charity. They are required lo declare any conflicts of interest and musl withdraw from
decision-making where conflicts arise. Details of any expenses reclaimed or related party transactions
can be found in note 8 of the financial statements.
Key Management
The Board entrusts the day-to-day management of Penny Brohn Cancer Care to the Chief Executive
Officer ICEOI, who is supported by a Senior Leadership Team. This team meets weekly to oversee
operations and actively participates in Trustee sub-committee meetings related lo their areas of
responsibility.
Public Benefit
The Trustees ensure that Penny Brohn Cancer Care continues lo deliver meaningful public benefit in
line with its mission and objectives. In doing so, they adher8 lo the Charity Commission's guidance on
Public Benefit under the Charities Act 2011. This commitment ensures that all activities are focused on
supporting those affected by cancer in the most effective and impactful ways possible.
Our Charltable Purpose
As outlined in the Articles of Association, Penny Brohn Cancer Care's charitable purpose is lo advance
health and well-being. as well as to alleviate sickness and distress, with a particular focus on supporting
those affected by cancer. The Trustees retain discretion over how these objectives are best achieved,
ensuring the charity remains adaptable to emerging needs.
Pay Policy
The CEO'S remuneration follows the same structured framework as that used for all employees and is
governed by the Executive Pay Policy. This poliw is regularfy reviewed by the People, Culture &
Inclusion sub-commillee, with oversight from the Trustee Board, to ensure fairness and alignment with
Sector stsndards.
Trading Subsidiary
To support ils charitable work, Penny Brohn Cancer Care operates a wholly owned trading subsidiary,
PB UK Commercial Ltd. This subsidiary generates revenue through commercial activities and donates
all taxable profits via Gift Aid to the charity. PB UK Commercial Ltd is managed by a Board of Directors,
which included two Trustees during the reporting year. The charity retains fLJII ownership of the
subsidiary s share capital.
Risk Management
The Trustees have implemented a comprehensive risk management strategy to safeguard the charity's
operations and long-lerm sustainability. This includes..
A formal risk policy, approved by the Board and subject lo annual review.
A Strategic Risk Register, which identifies potential risks and outlines mitigation strategies. The
register is reviewed regulady at Trustee meetings, with risks assessed based on impact and
likelihood.
A range of systems, policies, and procedures designed lo minimise potential disruptions and
ensure the charity can respond effectively to emerging challenges.
13

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNT
By maintaining robust govemance and proactive risk management, Penny Brohn Cancer Care
continues lo strengthen ils resilience, ensuring it can provide essential support lo people living with
cancer now and in the future.
Strategic Risk Register
Penny Brohn Can￿r Care Tecognises that strategic risks have the potential to significantly impact the
achievement of our core mission. These risks may arise from internal factors, such as financial
sustainability or regulatory compliance, or be driven by external events that are beyond our control bul
require a proactive response.
To manage these risks effectively, we maintain a Strategic Risk Register, which enables us to identify,
assess, and mitigate key threats lo our organisalion. This structured approach ensures that we remain
resilient, adaptable, and well-prepared to navigate challenges while continuing to provide high-quality
support to those affected by cancer.
The key strategic risks identrfied for the organisation are..
Financial sustainability: Our long-term financial sustainability remains a core strategic risk.
While we have Suc￿$$fullY diversified income streams in recent years, particularly through
growth in hospitality and commercial activity, we continue lo carry exposure through our
reliance on a small number of key funding and delivery partnerships. We are actively managing
this risk through focused engagement with partners and by continuing to grow a broader base
of income through fundraising, grant applications, and commercial diversification. Oversight is
provided by our Fundraising & Marketing and Commercial Su￿comMittees, and financial
planning is closely monitored by the Finance & Audit sub-¢ommittee.
Rising costs: Like many organisations in our sector, we are facing continued cost pressures
across energy, fty)d, and staffing. Increases to the National Living Wage and Employer National
Insurance contributions will raise the overall cost of delivering our services in 2025. We are
mitlgating this through ongoing value assessments, close budget scrLJtiny, and by exploring
operational efficiencies wherever possible.
IT infrastructure.. As our services evolve, so too do the digitsl and operational systems that
underpin them. To meet the needs of our stsff, client, and hospilalily clients, we continue to
assess and improve our IT infrastructure, including telephony, so￿are, and dats systems, to
ensure they are secure, cost-effective, and fil for purpose.
Each of these risks is actively monitored and managed through robust governance slruclures. including
oversight from relevant sub-committees and continuous evaluation of our financial, operational, and
strategic positioning. By maintaining a dynamic and responsive approach lo risk management. Penny
Brohn Cancer Care ensures that we remain well-equipped to fulfil our mission while safeguarding the
long-term suslainabilily of the charity.
Fundraising Standards
At Penny Brohn Can￿r Care, our work is made possible through the generosity and commitment of
our supporters. We take this responsibility seriously and are dedicated lo ensuring that all fundraising
activities are conducted ethically, transparenuy, and in line with best practice.
We employ a diverse range of fundraising approaches lo maximise our impact and support our vision.
These include di￿¢1 mail and email camp8igns, community and sponsored challenge events, and
dedicated fundraising events. We also welcome legacy and in-memoriam donations. work closely with
grant-giving trusts and foundations, and cullivale corporate partnerships to further our mission.
As 8 registered member of the Fundraising Regulator, Penny Brohn Cancer Care adheres to the Code
of Fundraising Practice, ensuring that our activities meet the highest standards of integrity and
14

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNTS
accountability. Additionally, we are proud to be an organisational member of the Institute of Fundraising,
further demonstrating our commitment lo excellence in fundraising.
All fundraising efforts are managed directly by our in-house team, and we do not engage third-paty
professional fundraisers or commercial participators lo solicit funds on our behalf. One exception is our
fundraising lollery, which is licensed by North Somersel Council and administered externally through
Unity Lottery (Sterling Management Centre Limiledl, a licensed External Lollery Manager IELMI
regulated by the Gambling Commission. We ensure full compliance with all relevant codes and laws,
including providing guidance on responsible gambling, self-exclusion options, and support for
vulnerable individuals.
Respect for our SUPFX)rters is at the heart of our approach. We are committed to ensuring that rbo one
is subjected to undue pressure or persistent requests for donations. Every communication includes an
option lo unsubscribe or opt out, allowing individuals to engage with us in a way that feels right for them.
Above all, we prioritise compassion and ethical engagement, particularly when working with vulnerable
individuals.
We are pleased to report that in the past year, we have received no complaints regarding our fundraising
activities, reflecting our dedication lo maintaining the highest standards of trust and accounlabilily.
Staff
In 2024, we saw an expansion of Penny Brohn Cancer Care's staff team with the introduction of several
key roles aimed at enhancing service delivery and internal operations. Recognising the importance of
collaboration, the charity implemented a Return to Office plan in October, designed lo bring teams
together and strengthen cross-organisational working. To support this transition, a new communications
plan was introduced as part of our hybrid working model, ensuring that staff remain connected and
engaged.
The Employee vol￿ group continues lo meet quarterly, providing staff with a platform lo discuss current
issues, share feedback, and raise questions directly with the Senior Leadership Team, CEO, and
Trustees. Additionally, Penny Brohn Cancer Care has reinforced its commitment lo equity, diversity, and
inclusion IED&I) by appointing two ED&1 Champions and training five staff members as Mental He8lth
First Aiders, ensuring a more supportive and inclusive workplace.
Volunteers
Volunteers remain an essential part of Penny Brohn Cancer Care's workforce, contributing over 5,000
hours of their time throughout the year. Their dedication is evident across multiple areas of the charity,
from maintaining the gardens al our National Centre to supporting retail operations al the Hub and
assisting with fundraising events.
Beyond these core roles, volunteer opportunities have continued to expand within client services,
allowing more individuals lo conlribul8 directly lo the charity's mission. Penny Brohn Cancer Care also
remains committed to fostering future generations, offering valuable work experience placements and
supporting Duke of Edinburgh students, helping lo cullivale skills and experience in those looking to
make 8 difference.
Clinical Governance
Ensuring the safely and quality of our client-f8cing services remains a lop priority al Penny Brohn
Cancer Care. Our commitment to clinical governance spans all aspects of service delivery, including
face-to-face, virtual, remote, and online resources. Through a robust quality assurance framework, we
continuously evaluate and refine our services to uphold the highest standards of safely, care, fairness,
leadership, and responsiveness.
15

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNTS
Our clinical governance framework is designed to safeguard the well-being of our clients, ensuring that
every individual accessing OLJr support receives the best and safest care possible. By maintaining a
structured and proactive approach, we remain dedicated to delivering ServI￿S that are not only effective
bul also aligned with Ihe evolving needs of those we support.
FINANCIAL REVIEW
Statement of Financial Activities {SoFAI
In 2024, the Group generated £2.159m in unrestricted income {2023'. £2.38m} and £269,309 in
reslricled income12023.' £379,561), leading to a total income of £2.429m12023'. £2.761 ml.
Our principal sources of income for the year were..
Income Source
Trusts and Grants
Services
and
Partnershi
Donations, Community and
Cor
orate Givin
Legacies
Retail & Hospitality
Total
2024 (£'0001
248
20231£'0001
257
Strategic
894
868
578
587
53
656
2.429
380
669
2,761
Ongoing economic pressures have meant that despite the progress made in 2023, the charity was not
able lo offset the general increase in costs by increases in fundraising income, resulting in a significant
deficit. Our long-standing partnership with Genesiscare has remained a reliable contributor to our
income base.
We were again grateful for the support of charitable trusts and foundations, including a generous
contribution of £100,000 from Walk the Walk, an enduring funder whose backing has enabled us to
deliver our'Feel Better, package of care and provide practical support for people preparing to Ljndergo
Chemo and radiotherapy and offset the side effects of their treatment.
Balan¢9 Shogt
The Group's nel assets redU￿d by £713,000. Current assets reduced by £92,000 as the increase in
debtors of £84,000 was offset by a reduction in cash of £172,000. Creditors due within one year
increased slightly as the charity drew down on a £200,000 credit banking facility. The mortgage on the
National Centre continued lo be ￿paid in line with expectations, resulting in a further reduction in long-
term liabilities.
Free reserves decreased by £152,000, bringing the year-end balance lo £122,000, while designated
funds, including the value of land, reduced by £476,000 to £4.950m. There was a post balance sheet
revaluation of the land and buildings, which redLJced the value by £377,000. Reslricled reserves also
reduced by £85,000 and lotalled £159,000 at the end of the year.
PB UK Commercial Ltd
Our trading subsidiary, PB UK Commercial Ltd, continued to operate key income-generaling activities
such as room hire and hospitality services al the National Cenlre, along with retail through The Hub and
our online shop. In 2024, the subsidiary delivered a profil of £41,00￿ solid continuation of Ihe
improvement seen in 2023, reflecting higher occupancy and retail footfall.
16

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNT
Reserves Policy
Penny Brohn Cancer Care aims lo maintain Free Reserves equivalent lo two months. payroll
costs, which equates to approximately £327,000 for the 2024 financial year. Al year end, our
free reserves stood at £122,000, which falls short of Ihis targel. However, Ihe charity's aim is to
get increase free reserves lo this policy level as quickly as possible.
This policy is reviewed annually and informed by projected income, liquidity needs, access to
credit, and overall financial risk.
The charity holds a £200,000 credit facility with Triodos Bank, offering vital flexibility in
managing short-lerm cash flow.
The National Centre was last revalued in May 2025 al £5.6m, with a remaining mortgage of
approximately £885,000 al the end of 2024.
Going Concern
The Finance and Audit Committee continues lo monitor financial performance closely, including regular
scrutiny of cash flow, income forecasting, and debt obligations. £200,000 of our creijil facility was drawn
upon during the year and continues to aid cash flow stability.
In light of current reserves, ongoing income diversification, and access lo secured borrowing, Ihe
Trustees have reasonable confidence in the charily's ability to continue operating for al least 12 months
beyond the date of this report. The going concern basis of accounting has therefore been applied in
preparing the 2024 financial slalements.
17

PENNY BROHN CANCER CARE
ANNUAL REPORT AND ACCOUNTS
Statement of trustees, responsibilities
The trustees (who are also directors of Penny Brohn Cancer Care for the purposes of company lawl
are responsible for preparing the Trustees, Report (incorporating the strategic report and directors,
report) and the financial statements in accordance with applicable law and United Kingdom Accounting
Stsndards, including Financial Reporting Standard 102.. The Financial Reporting Standard applicable
in the UK and Republic of Ireland (United Kingdom Accepted Accounting Practice}.
Company law requires the Iruslees lo prepare financial ststemenls for each financial year which give a
true and fair view of the slate of affairs of the charitable company and the group and of the income and
expenditure, of the charitable group for that period. In preparing these financial slatemenls. the Iruslees
are required to-
select suitable accounting policies and then apply them consistently.,
observe the methods and principles in the Charities SORP.,
make judgments and accounting estimates that are reasonable and prudent.,
slate whether applicable UK Accounting Standards have been followed, subject lo any material
epartures disclosed and explained in the financial slalemenls- and
prepare the financial slalements on the going concern basis unless it is inappropriate to
presume that the charitable company and the group will continue in busin8SS.
The Iruslees are responsible for keeping adequate accounting records that disclose with reasonable
accuracy at any time the financial position of the charitable company and group and enable them to
ensure that the financial statements comply with the Companies Act 2006. They are also responsible
for safeguarding the assets of the charitable company and the group and hence for taking reasonable
steps for the prevention and detection of fraud and other irregularities.
In so far as the trustees are aware..
there is no relevant audit information of which the charitable company's auditors are unaware.,
and
the trustees have taken all steps that they ought to make themselves aware of that information.
Approved by order of the members of the Board of Trustees and signed on their behalf by..
Stephen Rosser
Chair of Trustees
Dale.. 18 July 2025
18

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNT
Independent auditor's report to the members of Penny Brohn Cancer Care
Opinion
We have audited the financial statements of Penny Brohn Cancer Care (the 'parenl charitable
company'l for the year ended 30 November 2024 which comprise the Statement of Financial Aclivilies,
the Balance Sheet, the Cash Flow Statement and notes to the financial slatemenls, including a
summary of significant accounting policies. The financial reporting framework that has been applied in
their preparation is applicable law and United Kingdom Accounting Standards, including Financial
Reporting Standard 102.. The Financial Reporting Standard applicable in the UK and Republic of Ireland
Iunited Kingdom Generally Accepted Accounting Practice).
In our opinion, the financial statements..
give a true and fair view of the stste of the Group's and of the parent charitable company s
affairs as al 30 November 2024 and of its income and expenditure for the year then ended.,
have been properly prepared in accordance with United Kingdom Generally Accepted
Accounting Practice.,
have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted out audit in accordance with international Standards in Auditing IUKI IISAS IUKII and
applicable law. Our responsibilities under those standards are further described in the Auditor's
responsibilities for the audit of the financial statements section of our report. We are independent of
the Group in accordance with the ethical requirements that are relevant lo our audit of the financial
statements in the UK, including the FRC'S Ethical Standard, and we have fulfilled our other ethical
responsibilities in accordance with these requirements. We believe that the audit evidence we have
obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial slalements, we have concluded that the directors, use of the going concern
basis of accounting in the preparation of the financial ststements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to
events or conditions that, individually or collectively, may cast significant doubt on the Group's or the
parent charitable company s ability to continue as a going concern for a period of at least twelve months
from when the financial statements are aulhorised for issue.
Our responsibilities and the responsibilities of the directors with respect lo going concern are described
in the relevant sections of this report.
Other Informatlon
The Iruslees are responsible for the other information. The other information comprises the information
included in the annual report other than the financial slalemenls and our auditor's report Ihereon. Our
opinion on the financial statements does not cover the other information and, except lo the exlenl
otherwise explicitly slated in our report, we do not express any fomi of assurance conclusion thereon.
In connection with our audit of the financial stalemenls, our responsibility is to read the other information
and, in doing so, consider whether the other information is materially inconsistent with the financial
statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If
we identify such material inconsistencies or apparent material misstalemenls, we are required to
determine whether there is a material misstatement in the financial statements or a material
misstalemenl of the other information. If based, on the work we have performed, we conclude that
there is a material misstatement of this other information. we are required to report the fact.
We have nothing lo report in this regard.
19

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNT
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the 8udit'.
the information given in the trustees, report (incorporating the directors, report) for the financial
year for which the financial statements are prepared is consistent with the financial statements.,
and
the directors, report has been prepared in accordance with applicable law requirements.
Matters on which we are required to report by exception
In the light of our knowledge and understanding of the charitable company and its environment obtained
in the course of the audit, we have not identified material misstatements in the directors, report.
We have nothing to report in respect of the following matters in relation lo which the Companies Act
2006 requires us lo report to you if. in our opinion:
adequate accounting records have not been kept in the parent charitable company, or returns
adequate for our audit have not been received from branches not visited by us.,
the financial statements of the parent charitable company are not in agreement with the
accounting records and returns.,
certain disclosures of trustees, remuneration specified by law are not made., or
we have not obtained all the information and explanations necessary for the purposes of our
audit., or
Responslbllltles of trustees
As explained more fully in the Iruslees, responsibilities statement, the trustees are responsible for the
preparation of the financial statements and for being satisfied that they give a true and fair view, and
for such internal control as they determine is necessary to enable the preparation of financial statements
that are free from material misstslemenl, whether due lo fraud or error.
In preparing the financial slatemenls, the Iruslees are responsible for assessing the Group's and the
parent charitable company's ability to continue as a going concern, disclosing, as applicable, mallers
related lo going concern and using the going concern basis of accounting unless the trustees either
intend to liquidate the Group or the parent charitsble company or to cease operations, or have no
realistic allernalive but to do so.
Auditor's responsibilities for the audit of the financial $tatgments
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole
are free from material misstatement, whether due lo fraud or error, and lo issue an auditorfs report that
includes our opinion. Reasonable assurance is a high level of assurance, bul is not a guarantee that
an audit conducted in accordance with ISAS {UKI will always delecl a material misstatement when it
exists. Misslalements can arise from fraud or error and are considered material if. individually or in the
aggregate, they could reasonably be expected to influence the economic decisions of users taken on
the basis of these financial statements.
Our approach to identifying and assessing the risks of material misstatement in respect of irregularities,
including fraud and non-compliance with laws and regulations, was as follows..
we identified the laws and regulations applicable lo the charity through discussions with those
charged with governance and other management, and from our knowledge and experien￿ of
the sector-
20

PENNY BROHN CANCER CARE
ANNUAL REPORT AND A
OUNT
we focused on specific laws and regulations which we considered may have a direct material
effect on the financial slalements of the operations of the company, including the Companies
Act 2006, laxalion legislation and data protection, anli-bribery, employment, pensions,
environmental and health and safely legislation., and
we assessed the exlenl of compliance with the laws and regulations identified above through
making enquiries of management, inspecting legal correspondence and remaining alert during
the audit for any indications of non-compliance.
Our audit procedures in relation lo fraud included but were not limited to..
making enquiries of those charged with governance and other management as lo where they
considered there was susceplibilily lo fraud, their knowledge of actual, suspected and alleged
fraud.,
discussing amongst the engagement team the risks of fraud..
gaining an understanding of the intemal controls in place to miligale risks of fraud and non-
compliance with laws and regulations.,
testing journal entries to identify unusual transactions.,
assessing whether judgements and assumptions made in determining the accounting
estimates sel out in the accounting policies were indicative of potential bias,. and
investigating the rationale behind significant or unusual transactions.
There are inherent limitslions in our audit prO￿dureS described above. The more removed that laws
and regulations are from financial transactions, the less likely it is that we would become aware of non-
compliance. Auditing standards also limit the audit procedures required to identify non-compliance with
laws and regulations to enquiry of the directors and other management and the inspection of regulatory
and legal correspondence, if any. Material misstatements that arise due to fraud can be harder to delecl
than those that arise from error as they may involve deliberate concealment or collusion.
A further description of our responsibilities for the audit of the financial slatemenls is located on the
Financial Reporting Council's website al www.frc.or
.uklauditorslaudit-assurance-ethicslauditors-
res
nsibilities-for-the-audit. This description forms part of our auditor's report.
Use of our report
This report is made solely to the parent charitable Company's members, as a body, in ac¢ordan¢e with
Chapter 3 of Part 16 of the Companies A¢1 2006. Our audit work has been undertaken so that we might
stale lo the parent charitable company's members those matters we are required to state in them in an
auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or
assume responsibility lo anyone other than the parent charitable company s members as a body, for
our audit work. for this report, or for the opinions we have formed.
Joshua Kingston ACA (Senior Statutory Auditor)
For and on behalf of Burton Sweet Limited
Slatulory Auditor
The Clock Tower
5 Farleigh Court
Old Weston Road
Fl8x Bourton
Bristol BS48 1 UR
Dale..
18 July2025
21

PENNY BROHN CANCER CARE
CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME & EXPENDITURE ACCOUNTI
YEAR ENDED 30 NOVEMBER 2024
Llnrestricted
Funds
Restricted
Funds
Total Funds
2024
Total Funds
2023
Income from..
Don81ions arwj leg8CleS
charItsb￿ activibes
Other trading activities
Investments
Other income
598,914
5.450
655,911
440
11.3eAI
269.309
868,223
g05.450
65S,911
440
11,3eAI
1,213,809
876.120
658,621
376
9,725
Total income
2,159,351
269.309
2,428,660
2,760,651
Expenditur• on..
Raising funds
charl￿b￿ a¢uvMes
589,D27
1.821,694
589,027
2.175.943
618,019
2.047,462
354.249
Total expendlture
2.410.721
3Y.249
2.7￿.970
2.665.481
N￿10¥808 on invostmonts
14361
Net incomellexpenditurel forthe year
1251.3701
184,9401
1336,3101
94,734
Transfers between fund5
Loss on revaluation of fixed asset
1376.6291
1376.6291
Net movement in funds
1627.9991
184.9401
1712.9391
94,734
Total funds at the start of the year
5,699,569
244.330
5,943.899
5,849,165
Total funds at end of year
5.071,S70
159,390
5,230,960
5,943,899
The Group has no recognised gains or losses other than the results lor the year as set out above.
All of the aGtivities of the Group are classed as continuing.
See note 11 forlhe comparative Staternentof Financial Activities.
The notes on pages 26 to 42 forni part of thv&e financlal statements.
22

PENNY BROHN CANCER CARE
THE CHARITY'S STATEMENT OF FINANCIAL ACTIVITIES (INCLUDING INCOME & EXPENDITURE ACCOUNTI
YEAR ENDED 30 NOVEMBER 2024
Llnrestricted
Funds
Restricted
Funds
Total Funds
2024
Total Funds
2023
Income from..
Don81ions arwj leg8CleS
charItsb￿ activibes
Other trading activities
Investments
Other income
598,914
5.450
585,330
440
11.3eAI
269.309
868,223
g05.450
58S,330
440
11,3eAI
1.213,809
876.120
576,067
376
9,725
Total income
2,088,770
269.309
2,358,079
2,678,097
Expenditur• on..
Raising funds
charl￿b￿ a¢uvMes
559,D85
1.821,694
559,085
2.175.943
597,047
2.047,462
354.249
Total expendlture
2.380.779
3Y.249
2.735.028
2.644.509
N￿10¥808 on invostmonts
14
14361
Net incomellexpenditurel forthe year
I292.￿9)
184,9401
1376,9491
33,152
Transfers between fund5
Loss on revaluation of fixed asset
1376.6291
1376.6291
Net movement in funds
1668.6381
184.9401
753.5781
33,152
Total funds at start of year Irestatedl
5,710,108
244,330
5,954.438
5,921,286
Total funds at end of year
5.041,470
159,390
5,200,860
5,954,438
The Charity has no recognised goins or ￿SSeS other Ihan the results for the year as set out a￿ve.
All of the aGtivi118s of the charity are Glassed as continuing.
See note 11 forlhe comparative Staternentof Financial Activities.
The notes on pages 26 to 42 forni part of thv&e financlal statements.
23

PENNY BROHN CANCER CARE
BALANCE SHEETS
AS AT 30 NOVEMBER 2024
Company number.. 01635910
Group
2024
Charity
2024
Group
2023
Charity
2023
Fixed assets
Intangibl8 assets
TangiNe assets
Investments
12
11,501
6.332.201
6,129
5.837.650
6,129
5.837.650
6.131
6.332.201
6,131
14
5,843,779
5,843,781
6,349,831
6,349,833
Current assets
Stock
D8biors
Cash al bank and in hand
7,528
316,850
409.045
12.468
232.405
580.762
16
441.602
252.317
512,891
316.467
733.423
e93.919
825.635
829.358
credI￿r$.. amounts fallirvJ due within one year
17
1478.3281
1468.9261
1322.2671
1315.4531
Net Current assets
255.095
224.993
503.368
513.905
Total a88Ot8 le88 ¢urr6iit Ilabllltl88
6.098.874
6,068.774
6.853.199
6.863,738
Creditors." amounts falliry due after Tnore than one year
18
1867,9141
1867,9141
1909,3001
1909,3001
Net assets
5.230.960
5,200.860
5.943.899
5.9Y.438
FUNDS
Restrieted funds
Unrestricted funds
Genar81 funds
Designated funds lin¢ludirwJ rev81uation reserve of
£4,529.87412023". £4,785,261)
23
159.390
159.390
244.330
244.330
121.627
4.949.943
91,527
4.949.943
273.687
5.425.882
284,226
5.425.882
23
Total unrestricted funds
5,071.570
5,041.470
5,699,569
5,710,108
Total funds
5,230,960
5,200.860
5,943.899
5,954,438
The Trustees acknowledge th￿r responsibililEs for complwng with the requirements of the Act wlh respe¢ttO acc￿￿tir￿j records and yepar81ion
of financial sla18ments.
18 July 2025
These financial statements were approv￿ bythe Trustees on.............................................. and are signed their behalf by..
Stephen R05S8r
Ch8ir of Trustees
Tho not8$ on pallè8 26 to 42 fomi part of th￿ financlal 8tstomot)ts.
24

PENNY BROHN CANCER CARE
CONSOLIDATED STATEMENT OF CASH FLOWS
YEAR ENDED 30 NOVEMBER 2024
2024
2023
Not
Net cash inflowlloutllowl from operdting activities
19
1281,2151
398,016
NOn￿P￿￿tIonal cash flows=
I￿¥￿tIng a¢tlvlllo8
Payments fortangible fixed assets
Payments for iDiangible a$selS
Proceeds from disposal of fixed assets
Investment income
149,2421
178.7431
30.000
440
1.000
376
177.3671
Flnanclng actlvltl88
Loan repayments
Loan advancement
171.6841
200,000
171.6831
128,316
171.6831
Net cash inflowllouttlowl forthe year
20
171,717
248,966
Cashflow Restrlctlons
Charity law rxohibits the use of net C8sh infiows on any endowed or other reslricled lund lo oftsel nel Cash ouffiows ￿ 8nyfund outsKle its
own objects, 8xcept on speGial authority. In practic8, this restriction has nDt had any effect on cash flows for th8 year.
The notes on pages 26 to 42 forni part of these financial statements.
25

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
1 Accounting policies
A¢¢ountlng conv•ntlon
The financial statements have b8en prepared in acc￿danGe wth the historical costa)nvenlion lexceptwh8re oth8pNi8e slal8d in th8
accounting policy nolel and in accordance with the Ststemenl of Recommended Practice.. Accounting and Rewrknng by Charities preparing
ir accounts in 8c¢trdanct wilh the Financial R8porting Standard applicab￿ in Iht UK and Rtpublic of Ird8nd IFRS 1021 issu8d in October
2019. and Ihe Financial Reporbng Standard applicable in the United Kingdom and Republic of Ireland IFRS 1021, and the Companies Act
2006.
The charity is a public benefit entity as defined under FRS102.
Golng concem
The Charilys forecasts and projections show that the Charity expects lo operate within the level of its current debl facility. As detsiled in the
annual repDrt, thtr Ch*rity $*trk$ to in¢rtase incomtr from fundr8iging 10 8n8ble morè peoplè to 8¢¢es$ fr&8 Support lu hdp Ihtrm livè wtrll with
cancer. and allow us to Influen￿ the heahhcare agenda.
Th& Fin8n¢8 and Audit Commlll8& r•gu18rfy revi￿ v8ri0u$ rel•v¥nl report8 from the Ch8ri1y. including for8¢8s1 ¢a8h flow scenarios, 10 attasi
positively lo Ihe Charitys going concern slalus. This review is shared with the full Trustee Board al each Trustee meeting.
The Charily h8s iwo committed working capilal1oan facilities. 11 plans to continue lo hold these term debt facilities, secured on the Nat￿n￿l
CeDtre, th31 are used lo bridg8 tiTning gaps ID revenue raising. The Charity received a £50.000 BDunce Back103n in DeceTnb8r 2020, this
loan has a full1100%1 government-backed guarantee againstthe balan￿ of the facility. repayments of this loan commenced In December
2021. In Aprll 2025 Iha charity ¢onvaried a £200k Revolving Credit F8¢ilily thai w8s in pla¢$ al the end of the 2024 fin8naal ￿ar Snio a fiv8-
yeartemi ban. In addition lo these, the Charity holds a 10 year mortgage which expires in 2029.
The Truskes have a slru¢lured approach lo the financial slrakgy of the Charity. which Induded the 5 year pl8n reviewed byTruslees
annuallyfrotn which the 12 month budget and cashfknw foreGaSt 15 preparEA. Quarterly forecasts are also preparEA. TtU51ees review and
monitor the budgets and ¢ashfjow$ 81 each Trustees meeting. inlerr(galing vari8nce$. This ¢onlinuous monitoring 8nd wnlrol ensure the
T￿slee8 are abl£ lo properly review th£ Charity's going COnGem Status and ils finanGial viabilty. The Trustses review th8 Charitys forecast
and projections al each Board meeting and have a reasonable expectation that the Charity has adequate resources to continue In operational
8Aisi8n¢8 for a ptriod of ai It8$1 12 monihs folk)wing thè dai• of 8pprov¥l of Ih8sa financial È1818mtntÈ. Tht Group th8r•fo￿ ¢oniinu88 10
adopt the going con￿r￿ bas￿ for preparing Ils cons(Aidated financial statements.
Basls of eonsolldatlon
The ConsoliE18tsd Slalement of Finan¢i81 Acti￿ltIeS ISOFAI, C￿8011￿81e0 Babnce Sheet and ¢ons(rfidaled C8sh Flow Slalemenl consoliQ8ie
the financial slal8ments of the Charity and its Subsidiary, PB UK CornmerGial Ltd. The results of the subsidiary are consolida18d on a line by
line basis.
crftScal a¢¢ountlng ludg8m8llt8 and key Sources of ostlmatlon un¢8rtalnty
In the application of the charitys accounting policies. which are described In this note. Trustees are required lo make judgements, eslimales
and 8ssumpbons about Iht C8rrying valu6s of assets and liabilities thai ar6 not ￿adIlY appartni from Othèr sour¢ès. Tht tÈlimaies and
underlying a5sumplK)ns are based on historical e￿rien￿ and other factors Ihatare considered relevanL Actual resu115 maydrffer from Ihese
esum81e$.
The eslimale$ 8nd underlying assumplh)ns are revEwed on an woing b8sis. Revisions lo accounting estimaks 8re re¢conised in the
per￿d in which th8 8slimate is revised rfth8 affects onlythal p8ri(MJ or in the period of the revisi(￿ and firtur8 periods rf th8 revision
affects the current and future per￿dS
In the view of the Trustees, no assumpt￿nS Con￿rnIng Ihe fulure or estimation un￿rtalntyaffeC1lng assets aThJ liabilities at the balance sheet
dale are Ilkely lo wull In a makri81 adiuslmeni to Iheir ¢arrwng 8mounLS In the next Iinan¢l¥l year. The prin¢ip818¢wunling pollcies adopkd,
judgements and key sources of estirnation uncertainty in the presentation of Ihe financial stateTnents are outlined in the following paragraphs.
26

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
1 Accounting policies Icontinuedl
In¢omo
Income from donat￿nS is included in income when these a￿ re￿1vab￿. except as follows..
l. Wh8n dorbors sp8crfy thatd￿alIon8 givtrn to the charity musi b8 us8d in futtjrtr accounting P8riod8, th8 incomtr is défétred until thosa
Per￿d5..
11. When domrs impose conditions which have to be fulfilled before Ihe charity becomes entitled to use such income. Ihe income is deferred
Jnlil the pre-conditions have been mel.
Legocie5 are included on o receivable basis where the charity is enlided lo Ihe income. it can be measured reliably and receipt is tKobable.
Where leg*¢i6s have been notified to the charity. or the ¢h8rity 1$ ¥w8re of Ihe gr8niing of probait. and the criteria for Income recoynll￿n
have not been mel. then the legacy is not included in income but is Irealed as a contingent asset and disclosed rf material.
Investment income Is Induded on 8 reTriv8ble b851S.
Exp8ndhur
Expenditure is r8cognised onc8 there is a legal or conslTuclive obligation ID transfer economic b8nefil lo a third party, il is probable that
transfer of econom￿ benefits will be required In selllement and the amount of the oblwalion can be measured reliably. Expenditure Is
c18gsified by activity. Tht ¢o$i$ of 88¢h activity m8d6 up of ihè total of direct costs and $har8d costs. including suppori costs invofved in
undertaking each activity. Direct costs attributable lo a single activity are allocated direcuyto that activity. Shared costs which contribute to
more Ihan one 8¢1ivily and tsupport ¢o$ts which 8re not aiifibul8ble to 8 single ¥¢bvily 8¢ 8PPOrfioned between those 8¢livilies on ¥ ba$
consislentwilh the use of the resources. Central staff costs are alkncated on the basis of time SFent. and depreciation Gharges alloGated on
e portson of the asset's use.
Expenditure includes Bllributable VATwhieh cannot be recovered.
Ra181ng funds
R81sing funds expenditu￿ in¢lude8 those Costs Incurred in seeking voluntary conlribuiions, costs of gcK)ds sdd 8nd other cost8 whith include
Ihe costs of ￿nning and participating in fundraising events and collections and cost of goods purchased for resale.
Charitable Activities
Expenditure on charitable 8¢1ivilies Comprises those Costs ineurred by Ihe Ch8fity In the delivery of 11$ 8¢1ivilies and Servi￿$. It inckndes both
osls that can be allocated directly lo this activity and those costs of an indirect nature necessary la support them.
Support costs and other costs that cannot be direcdy attributed lo activities are alkncated on a basis consislentwith the use of the resource.
Governan¢e ¢o$ts
Governan￿ costs include those costs associated with meeting the conslilulional and statutory requirements of the charity and include the
audit fees and Costs linked lo the sir8legi¢ m¥n8gemenl of the charity. Governance costs are Induded within support costs.
Pènsion Go8t$ and other pOst￿etIrement benefits
The charily Coniribuies 10 defined ￿￿tributIOn pension schemes. Contributions p8yable to the charit￿8 pension 8¢hemes are ¢h8r9ed 10 the
Statement of Financial Activitses the peritM4 to which they relate.
Intanglble assets
IntsDgible ass81s CDsling £500 or rnore are capitalised and recognised when future economiG b8nefftE ar8 probable and the cost or value of
Ihe asset can be measured rdiably.
Intangible assets are initially recognised at cost ￿sS accumulated amortisalion and impairment. AmortIsal￿n is calculated so 35 lowrite off
tre ￿81 of an ¥ssel, less Ils eslimaled ullimsle residual value, overlhe useful life of th81 asset 8s follows..
Computér $oftw8r6
20'k straight linè basis
27

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
1 Accounting policies Icontinuedl
Tanglbl8 fix￿ assots
Freehold buiklings are Included al v8lu¥lion based on open marf(el vtlu¥lion. Valuations tre pthrmed every five yetrs. All other tsngiNe
fixed assets are inGlud8d at Gost less accumulated depreciation. Tangible fLYed assets costing £500 or mor8 are capitalised and recognis8d
when future economic benefits are probable and the cost or value of the asset can be measured reliably.
The Trustees of the charity catry out an annual Impairment rewew of the properties.
DepreGiation is calculated lo write off the cost orvalualion of tangiblefixed assets, ￿55 its estimated uthmate re5￿Ual value, over the useful
life of Ih¥l 8s$el as folbws.
Frtehold prop8rty
Long-lerm leasehold pr(perty
Fixtures arbd fittings
Computer equipment
2% Sirai9hl lint on buildings, no dfrpreu8i￿n charyed on L8nd
b8sed upon the length of the lease
5 to 10 years straight line basis
3 10 5 years siraighl Line basis
Inve5ttnerbt property
Thrj land and buildirbgs that constitu18 th8 National Centr8 of Penny Brohn CarbGer Care form a mixed us8 property where dem8nls of th8
propety are used for charitable purposes and elements are let or used commercially. As the Investment property elements are not separaNe
and Ihtr fair valut cannot be m8*sur&d reliably, the tniiré proptrty 1$ acmunled for 8$ proptrtywlhin tan9iblt r￿ed a$strts.
Fixed asset investment5
Fixed asset Investments ?re a form of fin8n¢i81 instrument and are Inits8lly re¢ogni$ed 81 Iheir Ir8nsa¢lion cosl ¥nd subsequently measured al
fairvalu8 al the BalarbGe Sheet date. unles5 the valu8 Gannot be Tneasured reliably in which case il is measured al cost less impairm8nL
Investment gain$ 8nd loss, whether real￿e￿ or unrealised are combined and recognised a$ 8 gain or loss ￿ investments In the SOFA.
Investments in subsidiaries and associates are included at cost less impairment at 30 November in the charitys accounts.
Stock
stocks ar$ valu6d 81 Iha lower of cost 8nd net rtra11s8bla v8lua, after maklng due allov4an¢& for obsolala and slow moving itèms. Cost includes
all direct costs and an appropriate proportion of fix￿ and Variable overheads.
Donated items are not valued in stock and are rewgnised in income ontywhen sold.
Cash and cash equlvaltnts
C8sh ¥t b¥nk and cesh in hend In¢luLles Cash and short term highly liquid investments with a short mtlurity of three month$ or less from the
da18 of acquisition oropening of the deposit or sitnilaraccounl.
Financial instruments
Tht ¢h8rty has tle¢16d 10 apply thé provisions of S8ction 11 '6asic Financial In$irumèni$' and S8ction 12'0th•r Fin8ntri81 In8trumtnts Issues,
of FRS 102 to all of its financial inslrumenls.
Financial instruments are recognised when the charity become5 patyto the contractual provIs￿nS of the instruTnenl. Financial asse15 and
Iiabiliiies are offsei. with Ihe nel amounts presented in the financial slalemenls, when ihere is ¥ legally enforceable right lo sel olf the
re(￿nISed amounts and there is an intention 10 5&tt1e on a net basis or to realise the a5sel and settle th8 liatwlity Simultaneously.
Basic financial assets. whiGh include trade and other r8C8ivables and cash and bank balanGes. are initially measured at transaction price
including transaction costs and are subsequendy carried al amortised cost using the effective interest rneth￿ unless the arrangement
constilul8s 8 fin8nciw transaction. where th8 financial ¥8È&t 1$ measured at tha pr888ni v8lu8 of th& futu￿ r8C8ipls discountsd ai 8 m8rk81
rate of interest.
Basic financial liabilitiès. including trade and othèr payables, and loans from group und&rt8king$, arè initially r6¢0gni8ad al transaction pri¢8
unless the arrangement conslitules a financing tronsact￿n, where the debt instrument is measured atthe present value of the fulure
paymanls dlscounted ai 8 m8rk$l rale of Inte￿$1.
28

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
1 Accounting policies Icontinuedl
Fund ac¢ountlng
General funds are unrestricted funds which ore available for use al the discretion of Ihe Trustees in furtheronce of the general objectives of
Charfly and which hava not been das￿nated for otrtsr purposes.
Designated funds cornprise unrestricted funds that have been sel aside bythe Trustees for particular purposes. The aim and use of each
designaied fund is sel out in the notes ￿ the finanty81 stslemenls.
Restricted funds can only be used for parbcular reStr￿ted purFK)ses within the objects of Ihe charity. Restrictions arise when specrfied bythe
donor or whtrn funds raised for parb¢ul8r restricted pJrposas. The costs of ralsing and adminlslerlng $u¢h funds 8r8 charged against the
specffic fund.
Furiher explanabon of the nature and purpose of each fund is Included in the notes lo Ihe fin8ncio1 statements.
Invesimeni income. g81ns and losses are allocaied Lo the appropr181e fund.
2 Income from donations and legacies
Group & Charlty
Unrostsictèd
Funds
R8stridod
Funds
Total Fund8
2024
Genèral don81ion$
Donations from regular givers
Legacies
469.124
76.514
53,276
269.309
738,433
76.514
53,276
Total for Group & Charity
598,914
269,309
868,223
Prior year
Unrestricted
Funds
Restricted
Funds
Total Funds
2023
General donations
Donations from regular glvfrrs
Donations to purchase land
Legacies
538.123
63.076
206.150
744.273
63,076
26.411
380,049
26.411
147,000
233,049
Total for Group & Charity
834,248
379,561
1.213,809
3 Income from charitable activities
Group & ¢harlty
Unrestricted
Funds
Restricted
Funds
Total Funds
2024
Total Funds
2023
Sèrvicé ￿ntrated in¢om• from par￿[shIpS
Other service generated income
Catering income
894.303
894,303
834,462
33.607
10,061
11,035
11.035
$05,450
905,450
878,120
AJI income re￿Wed forcharilable aclnfilies in the pr￿r year was unrestricted.
29

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
4 Income from othertrading activities
Unrnstrl¢tgd
Fund5
Rèstrl¢t8
Fund5
Totsl Fun(J$
2024
Total Fund$
2023
Trading income..
Facilities inGome
The Hub
PB UK Comrneraal- management charges
88,152
108,372
388.806
88,152
108.372
388,806
61,903
100,408
413,766
Totsl ¢h8rfty
585.330
585.330
576.067
PB UK Commercial income
Inter￿roup activity
459,387
1388,8061
459.387
I388.8￿}
496,310
1413.7561
Total Group
655.911
655.911
658.621
JI Income re¢eNed forolher Ir8ding 8clivilies in the prior year was unreslrided.
5 Expenditurè on raising fund8
Current year
Total Funds
2024
Total Funds
2023
The Hub
Fundraising support costs
128,924
430.161
116,979
480.068
Totsl Charity
5S9,085
597,047
PB UK Commercial- management charges
PB UK Commerci81 Olhtr trading tIP8ns8S
Inter￿roup activty
388.806
29,942
1388.8061
413,756
20,972
1413.7561
Total Group
589.027
618.019
6 Exp8ndltur8 on charftablo actIv￿leS
Support
Costs
INote 71
Dlre¢t
Costs
Totsl Funds
2024
Group & Charity
Online services
In-personlgroup services
One lo one sfrrvicss
Partnerships
93.452
57.311
266.844
701.616
330,314
64.934
39,822
185.415
206.719
229,516
158.386
97,133
452.259
8,335
559,830
Group & ¢h¥rilytOtsl$
1,449.537
726.406
2.175,943
30

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
6 Expenditure on charitable activf(ies Icontinuedl
Support
Cost$
(Note 71
Prlor year
Dlr8¢t
Costs
Totsl Fun(J$
2023
Online services
In persoTrl group serwces
One lo one servi¢e$
Partnerships
168.056
24,937
184.499
704,311
269.845
86.513
12,837
.978
362,572
138,914
2￿.569
37,774
279,477
1,066,883
408,759
Group & ¢harilyt0181s
1,351.648
695,814
2.047,462
7 Support costs
Support costs are allocated between raising funds and Charitab￿ activthes on the basis of staff time.
Support costs. Included in notes 5 & 6. are as folbws..
Current ￿&r
Fundraisiny
and
publicty
Charftable
Activitie5
Total
2024
Stsff costs
Olhercosls
Office costs
Building costs
Finance costs
Governance costs
277.813
69.062
21,972
49,689
6.514
224.691
502.504
69,062
153.609
349,015
46,477
35.900
131.637
299.326
39,963
30.789
Group & charilytolds
430.161
726.406
1.156.567
Prlor y88r
Fundralslng
and
publicty
Chaiitable
Activities
Total
2023
Staff costs
Other costs
Office wsts
Building D35ts
Finance ¢osis
Governan￿ costs
310.496
73,917
28,955
53.162
6.654
6.884
210.426
520,922
73,917
175.882
322,923
40,421
41.817
146.927
269.761
33.767
34.933
Group & charitytotas
480.068
695.814
1,175,882
8 Not Incom￿{8xp$nd6turSl for th8 year
This Is $18lad after charging..
Group
Char
2024
2023
2024
2023
Auditorfs remunerabo)
for Stslutory audil seivi¢es
for accounts preparation
13.060
4.090
12.150
3.800
9.480
2.475
8.800
2.300
T￿slee3. r8mun8ralion
Trustees. travel. meeting and training expenses- n￿e[2023.. 1 Irusteel
Amorhsation
Depre¢i81ion
64
17,271
99,081
17,271
99.081
111.896
111.896
Donations trom Trustees and related parties ¥mounted to £73412023.. £1.7201.
31

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
9 Staff costs and numbers
The 8ggreg8le p8yrdl costs were..
Group
har
2024
2023
2024
20rJ
Wages & salarEs
SoGial security costs
Pension contributions
Redundancy payments
1.735.274
134,756
81,338
1.667.778
130,139
78.774
9,368
1.735.274
134,756
81.338
1.667.778
130,139
78,774
9,368
1,951,368
1,886.059
1,951,368
1,886,059
The average weekly number of empbyees (including senior managemenmeadership tearnl during the year was..
Group
Charty
2024
2023
2024
2023
Staff
109
106
109
106
The number of empbyees whose ernployee benefits lexcludirwJ e￿￿0Ye[ ￿nS￿n costs) eX￿eded £60,000 was..
Group
Char
2024
2023
2024
2023
£60.WO-£69,999
£70.(M)0- £79.999
Key management personnel
The lolal employee benefts of the key manageTnent personnel for the year w35 £86,96612023.. t80,3061.
10 Taxotlon
The charity is eAempl from Corporation tax on ils Charitable a¢Uvilles.
32

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
11 Statement of Financial ACti￿tieS comparative figure5
Group
Forthe yearended 30 November 2023
UnrostsS¢tgd
Funds
R8strl¢to
Funds
Total Fun(J$
2023
Income from..
Donations and legaGies
834,248
878.120
658.621
376
9,725
379,S61
1,213,809
878.120
658,621
376
9.725
Other trading acti￿lieS
Inve$itDents
Other Income
Total income
2,381,090
379.561
2,760,651
Expendlture on=
Raising fund5
Charitable act5￿1￿￿$
618.019
1,802.000
618.019
2.047.482
245.482
Total oxpondthr•
2,420.019
245.462
2.665.481
Net losses on investments
14361
Net incornellexpenditurel for the year
139.3651
134.OQY
94.734
Transfers belw&n funds
148.4541
48.454
Net movement between fijnds
187.8191
182.553
.734
Totsl funds at start of year
5.787.388
61.777
5.849.165
Total fund5 at end of year
5,699,569
244,330
5,943,899
Charity
Forthe yearerbded 30 November 2023
Llnrestricted
Funds
Restricted
Funds
Total Funds
2023
Income from..
Donations and lÉgacits
834.248
878.120
576.067
376
Y,725
379.561
1.213,809
878.120
576.067
376
Y.725
Other trading acliwlies
Invtsim&nts
Other Income
Total incorne
2,298.536
379,561
2,678,097
Expenditure on=
Raising funds
597,047
1,802.000
597.047
2.047.462
245.462
Total expendiiure
2,399.047
245.462
2,644,509
Net10sse$ on Investments
14361
Not In¢omo118xpgndfjtursl for th8 yoar
1100.9471
1Y.099
33.152
Transfers beiween funds
148.4YI
48.454
Not movemont botwo•n
182.553
33.152
Totsl fund8 at Start of year
5.859.509
61.777
5.921.286
Total funds at end of year
5,710.108
244.330
5.OM.438
33

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
12 Intangible assets
Comput8r
Softwaro
Group and ¢h8rfty
Totsl
Cost
At 1 December 2023
Additions
86.360
16
86.360
16
AI 30 Novambtr 2024
86,376
86,376
Amortisation
Al 1 Dectmber 2023
Charge for the year
74.859
74,859
At 30 November 2024
86.376
86.376
Not Book Value
AI 30 Novémbtr 2024
AI 30 November 2023
13 Tangible fixed as5et5
Long-t8m)
leasehold
property
Freehold
property
Flxtures and
littings
Computer
equlprr￿nI
Group and charity
Total
Cost orvaluation
Al 1 Dectmber 2023
Additions
Disposals
Rev8luallon
6.754.337
117,589
2.900
120.297
43.280
13,5521
65.382
3.062
13,8051
7.057,605
49.242
161,0651
11.060.629)
153,7081
11.060.6291
AI 30 November 2024
5.640.000
120.489
160.025
FA.639
5.985.153
Dtrprè¢iation
Al 1 December 2023
Charge for the year
Eliminaitd on disposal
lrnpairmenl on revaluation
612.000
72.000
47.197
12,025
35.681
17.157
11.9921
30.326
10.714
13.8051
725.404
111,896
15.7971
1684,0001
1684.0001
At 30 November 2024
59.222
51,046
37.235
147,503
Not book valuo
AI 30 Nov•mb&r 2024
5.640.000
61,267
108.979
27.404
5.837,650
AI 30 November 2023
6.142.337
70,392
84.416
35.056
6.332,201
It is Penny Brohn Cancer Care's policyto revaluefr&hold prO￿ty every 5 years. The freehold property was revalued in May 2025 by
Lambért Smiih Hampion. a firm of valutrs •K16rnal to th& Charily. The prc4)8rt￿s opan m8rk81 valut was ¢onsid•rtd to b8 £5,640.(M)O In
accordance with the RICS valuation model.
Thtr historical cost of Ihtr ravalued freahold propèrty ass81s amounts 10 £1.110,12612023". £1.356,3761.

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
14 Fixed asset investment5
Grou
Charty
2024
2023
2024
2023
Listed investments
Al 1 December 2023
Unrealised gainl Ilossl
Unlisted inve5trnents
Investment in Subs￿l8rY
6,129
6.565
14361
6.129
6,565
14361
6.129
6.129
fj.131
6.131
Sharas in 9roup undertaking8 8nd p8rtiUP81ing inierasts.
Subsidiary
Undertakings
Total
Cost
Al 1 Dectmber 2023 and ai 30 Novwnb8r 2024
Details of undertakings=
Country ol
In¢orporatlon
Proportfjon of Votlng rlghls
and 8har88 held
2024
2023
Company name
Holdlng
PB UK Commerty81 Ltd
England and W81es
Ordinary
100%
100%
Principal a¢tivitlO8
Other retail sale of new gO￿S in specialised stores
Other retail Sale not in stores, sta115 or markets
Other a￿0mmOd8￿on
PB UK Commercial Ltd
Yearended
Yearended
30 Nov 2024 30 Nov 2023
Turnov8r
Cost ol sales
459,387
1403.7651
4￿,309
1427.3621
Gr088 prof
55.622
68.947
Administrative expenses
114,9831
17,3631
Operating profit
40,639
61,584
Interest pay8bk ¥nd simibr ¢h8rges
Profit b6for6 taxation
40.639
61,584
Tax charge for the year
Profitfor the pertod
40.639
61.584
Retained earnings brought fory*ard
110,5371
Retalned eamlngs carrled forwar
10.537
35

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
15 Stock
Grou
Charty
2024
2023
2024
2023
Finished goods and goods for resale
7.528
12.468
16 Debtors
Group
Charty
2024
2023
2024
2023
Trade debtors
Amounts owtd by yroup urKJertakiTrJ8
Other debtors
Prepayments and accru8d income
96,433
105.112
87,960
133,225
20.370
200.047
76,334
309,459
1.450
12S,648
20.370
2W.047
1,645
12S.648
316,850
232.405
441,602
512,891
17 Creditors.. amounts falling due wthin one year
Grou
Charty
2024
2023
2024
2023
Bank loans
Other loans
Trad8 creditors
Amounts owed by group undertskityJs
Other taxal￿n and s(Kial security
Olhercredilors
Accru¥ls tnd deferred In￿Me
31.160
210.225
85,334
30.114
Y,973
114.617
31.160
210.225
84.784
30,114
Y.973
114,012
75.455
22,347
53.807
74,431
27,903
65.229
75.455
22,047
45.255
74.342
27,603
59.409
478.328
322.267
468.926
315.453
Loan tsalibes al the yaar end aro wlh NalW&sl Bank and Triodos Bank, Secured on the freahold proparty oftha Charity.
Deferred incorne
Group
Charty
2024
2023
2024
2023
Al 1 December 2023
Amounts released trom previous peri(rtls
Resources defer￿ in the period
10.597
110,5971
20.716
8,744
18.7441
10.597
10,597
110.5971
20.716
7,S73
17.5731
10.597
At 30 November 2024
20.716
10,597
20,716
10,S97
18 Creditors.. amounts falling due after one year
Group
Charty
2024
2023
2024
2023
Bank loans
Other loans
856,547
11.367
887.706
21.594
8￿,$47
11.367
887,706
21.594
867.914
009.300
867.914
009.300
Loan facilthes al the year end are wlh NalW8sI Bank and Triodos 8ank, secured on the freehold property of the Charity.

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
19 Reconciliation of net movement in funds to net cash inflow from operating activities
Group
2024
2023
si8iemeni of Financial A¢tivlti&S'. N61 movament in funds
Loss on investments
Loan interest
Investment income
Loss on disposal of fLKed asset
Amorbsaiio
Depwi81ion
Increase in operational creditors.. current liabilities
Decr88s6 in optraiional d•biorÈ
Decrease in stock
1336,3101
94,734
436
24,824
13761
3,793
17,271
99.081
40,834
111,453
5.966
31,S96
14401
5,268
111.896
145,2371
164.4451
4.940
Net cash Inflowlloutflowl from operatlng actfvltle5
281.215
398.016
20 Analysl$ of Changes It) ¢ash durlng tho year
2024
2023
Change
Cash at bank and in hand
409.045
580,762
171,717
2023
2022
Change
Cash at bank and in hand
580.762
331.706
248.966
21 Anafy5i5 of Ghanges in net debt
Current year
At1Dee
2023
Operatlng
cash flow5
Investlng
rash flows
Flnanclng
cash flows
At 30 Nov
2024
Cash al bank and in hand
Debt due within one year
Debl dLE after more th8n one year
580.762
140.0871
1909,3tK)I
1281.2151
128.316
1201.2981
41.386
409,045
241.3851
1867.9141
Tol81
368.625
281,215
18.818
31.596
700,2
37

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
22 Movement in funds
At1D8¢
2023
IncomA and
galns
Expgndf(ure
8nd10$so5
At 30 Nov
2024
Fortho yoor ¥nde(J 30 November 2024
Yran$tsr$
R•$trlct8d funds
Bristol Whole Life Approach in Scouand
Library
Lymphoedema
Nutritio
OlhersTn811 donat￿￿5
Penny Brohn on the Hvjh Street
Reg￿nal donations
11.288
7,293
119.714
111.2881
16,9291
165.6521
116,0001
15001
364
54,062
15.000
soo
10.035
10.035
3,000
13.0001
2.275
2,275
3.000
21,960
22.478
16,667
Remote SeNi¢es
Treatment Support
Walk the Walk
Walk the Walk F881 Better Package
Counselling
IT
Garden Room Roof
enopause
Residential Retreats & Wellbeing Days
Music & Arts
Nicola Corey Fund
61.400
21.960
158.4001
93.725
171.2471
183.3331
127.5001
11,8661
13.9361
4.9981
10D.000
27.500
1,866
15.000
10.198
3,427
3,000
6.458
11,064
5.200
3,427
2,400
6.458
ieooi
244.330
269.309
354.249
159.300
Unrestricted funds
Designated funds
Capital fund including revaluation reserve
G8n8r81 fund
5,425,882
284.226
1536,2321
12,221.1761
60,293
160.2931
4,949.943
91,527
2.088,770
5.710,108
2.088,770
2,757.408
5.041,470
Totsl funds Charlty
5.954.438
2.358,079
3.111.657
5.200,860
PB UK Commerti*l Ltd
Inter*nlity transactions
110.5371
459,387
1388.8061
1418.7481
388,806
30,102
10.539
29.942
30.100
Total fund5 Group
5.943,809
2,428.660
3,141,599
5,230.960
38

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
22 Movement in funds Icontinuedl
Fortho yoor ¥nd8(J 30 November 2023
At1D8¢
2022
At 31b Nov
2023
Income
Expenditure
Tran51ers
Restricted funds
Bristol Whole Life Approach in Scouand
Homeopaihr ylol
Library
Residential R81reats & Wellbeiny Days
Lymphoedem¥
Nutrition
Ont 10 On•
Other small donat￿nS
Penny Brohn on the High Street
Region81 donations
Relaxation chairs
Remote ServiGes
Twlmenl Support
Walk the Walk
Land fund
11.288
9.000
8,500
12.580
22.652
11,288
19.0001
11,2071
112.5801
150.1381
115.2501
7.293
147.000
15.250
458
119.714
2.704
230
51,297
141,2621
11.8001
12.6201
149,1001
12.8381
166,2751
1D,035
1,800
4.895
11,000
2.296
2,275
38,100
542
150.000
26,411
93.725
174.8651
48.454
61.777
379,561
245.462
48,454
244,330
Unrestricted funds
Desi9Traled funds
C¥pilal fund including revaluation reserve
General fund
5,398.728
460.781
1141.17fj1
12,258.3071
168.330
1216.7841
5.425.882
2￿,228
2,298,536
5,859.S09
2,298,536
12,399,483>
48.4541
5,710.108
Total fund5 Charity
5,921,286
2.678,097
2,644,94S
5,954,438
PB UK Commercial Ltd
Inter-enlity transactions
496,310
1413,7561
1434.7281
413,756
110,5371
72.121
82,554
20.972
10.539
Total funds Group
5.849.165
2.760.651
2.665.917
5.943.899
Rèstri￿td fund$
Bristol Whole Lile Approach in Scotland
The Bristol Whole Lrfe Approach in Scotland was a pilot projectto work in partnership with Dumfries Hous8 in Ayrshire, giving us the chance
to lake our Bristol Vlhole Life Approach lo those living with cancer in Scoll8nd.
Hom8OPathi¢ pilot
A grant was received from Nelsons lo run 8 Homeopathy project with Ihe N81ional Centre for Integr81ive MedicirE INCIMI providing Individual
consultations lo Penny Brohn UK Clients.
Library
Following the ￿-purp0S1ng of thi5 grant in 2023, we recruited a parttime information and resource officer with the balance of the fund t￿Ing
sed lo pay for 8n associate to support the relevant work.
Rtrsldtntlal Rotrtrats & Wtllbolng Day¥
Funds had been received in prior years to support those attending our in-person retreats and wdlbeing days.
Lymphoodoma
A rostriclad 16gacy w8s recwved lo make special facilities available to Ihosa ￿l￿niS sufferlw Y￿th Lwrphoedèm8. A Iwnphoedam8 workshq)
takes place each month led by a specialist lymphoedema practi1￿ner.
39

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
22 Movement in funds Icontinuedl
Nut￿tIOn
Gerald Micklem Chgritable Trust supportthe S8￿ry costs of our llLrtrition lead who is responsible for leading and managirvJ the development
and delfvery of Safe. affectiva. hlgh qualilyonline arvj In-parson nulrillon services.
One to One
Funds were received in November 2022 from The W8instock Fund and in 2023 frDm The Ann8ti Trustfor Onfrlo-one's ￿th an ini8grallve
doctor.
Other small donatlons
A donation had been received in 2022 to cover the cost of Tnovement exercise this arnount has been fully spent in the prioryear.
A donation of £500 was received from Quartèt Community Foundation resirided 10 th6 PUrthas& of kitchèn 8ouipm&nt.
Penny Brohn on the High Street
Rtslricled funds had been retré1v￿ from th8 Ntrwby Charit8bl8 Trugi to providtr Psychological servicès 81 Thtr Hub. This fètr&io-f8¢tr s8rwc8
provision was dela￿ due Covid restrictions
Reglon81 donatSons
A donation was received from J & M Brit￿￿ Charitable Trust for use in Bristol area.
Relaxation chairs
The relaxation Chairs find is 8 grant lo en8b￿ us lo upgrade and repl8ce our rel8X81ion chairs.
Rtrmtsta Sorvi¢68
We Gonlinu8 to provide our prograTnme of onlirbe 5UPPOrt Ihroughoutlhe y8arwlh nat￿nal reach for peop18 affeGt8d by cancer, continualty
reviewing and adapbng our offering. These funds have enabled us lo grow this seTrice and embed Il as part of our hybrid Servi￿ model.
Grants have been recerrfed frotn The Tim Ti18y Bursary Fund, Th8 Hdianlhus Charit8b18 T￿$1, Th8 WeinstoGk Fund. The HiL¥ry Awdry
Charitable Trust, The February Foundation 3nd The Medlock Charitable Trust.
Tr8atmont Support
Our online Treatment SuppDrt Programme was supported by a grantfrom The Annet charitab￿ Trust.
Walk thè Walk
A grantwas re￿iVed from Walk the Walk in 2023 to support and grown our in-person serv￿eS On￿ again through specialist Wellbeing days
and ra8id$niial wlraals.
Land furbd
Fund restricted lo the purchase of ¥dj8ceni land lo the Nabonal Centre and 8880¢ialed Costs. The iransfer in the prior year represents the
spend above restricted income, made frorn general fund5.
Do8lgn81od funds
Capltal lund and r8valuatlon r88orv
The Capital fund repwsenis lh8 nel book value of18ngibl$ and InlangiNe flxed assets. lass loans secured on the relavanl assets. The
revaluation reserve totals £4,529.87412023." £4,78S.2611 al the year-8nd.
Walk the Walk Feel Better Package
A grant was re￿iVed from Walk the Walk to prO¥￿e a'Feel Betterf support package building on of ourflagship Treatment Support
Programme the furhds enabled us lo develop.'how-to' resources, online group sessions and specialist wellbeing days.
Counselling
Support was received from the N8wbyTrusl Ltd to SUPPDrt Durcoun8811ing programTne through the fundin9 of a counsellor whowould offers
on&lo4)ne counselling. and facilitating an emotional support group. The Albert Hunt Trust and Abbvie UK provided grants to support our one-
ttrone ¢ouns611ing $8s8lon8.
IT
Funds were provided lo enable us to purch8se three new bplops.
40

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
22 Movement in funds Icontinuedl
Gardèn Room Roof
Donations were tnade byThe Screwfix Foundation and The Will Charitable Trust for repairs lo Our Garden Ro(xn roof.
Menopause
A grantwas received from Si￿ad lo provide specialist menopause sessions, Wellbeing days and reSoUr￿S for those clients experiencing
earlyon$el menopause 8s a result of Ih¥r c8n¢er Ire8lments.
Residential Retreats & Wellbeing Da
Funds had been received from D,0￿eY Carte for 8 Wdlbeing D8y tsking ￿4¢e in December 2024.
Mu81¢ & Arts
Funds We￿ received The Joyce Fletcher Charita￿e Trusi lo fund our weekly 8rt sesslons and support speclallsl muslc and 8rt wellbeing
days.
Nicola Corey Fund
Bursaries are aVaila￿e lo support parents with a child under the age of 16 to support with the support of childcare, transport or
accommodation al our National Cenlre, where the p8reni hes a cancer diagnosis.
23 Analysls ot net osset$ between funds
Charlty
As at 30 November 2024
Unre8trictod
Deslgnated
General
Fund5
Funds
Restricted
Funds
Total
2024
Tangible fixed assets
Fixed asset invesknents
Current assets
Creditors due within one year
Creditors over one ￿¥r
5,837,650
5,837.650
6,131
5Y.529
1437,7661
111.3671
159.390
693,919
1468,9261
1867,9141
131,1601
1856.Y71
Total charlty
159.390
4,949.943
91.527
5.200,860
A8 at 30 November 2023
Unrestricted
Doslgnated
General
Funds
Funds
Ro8trl¢ted
Fund5
Total
2023
Tangible fixed assets
Intangible fixed assets
Fixed ¥$$el Invt$imenl$
Current assets
Creditor5 due within on8 year
Creditors over one year
6.332.201
6.332.201
6.131
585.028
1285.3391
121.5941
6,131
829,358
1315,4531
1909,3001
244.330
1887.7061
Totsl Charlty
244.330
5,425.882
284.226
5.9Y.438
41

PENNY BROHN CANCER CARE
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 30 NOVEMBER 2024
23 Analy515 of net assets between funds Icontinuedl
Group
A5 at 30 November 2024
Unrèstrl¢tsd
Designated
General
Funds
Funds
Restricted
Funds
Total
2024
Tangible fixed assets
Intsngible fixed assets
Fixed asset Investments
Current 8SS@IS
Creditors due Wilhin one year
Creditors over one year
5,837.650
5,837,650
6,129
574,033
1447.1681
111.3671
6.129
733,423
1478.3281
1867,9141
159,390
1856.5471
Total Group
159,390
4,949,943
121,627
5,230,960
As at 30 November 2023
Unrestricted
Designated
General
Funds
Funds
Restricted
Funds
Total
2023
Tangibl8 fix8d assetg
Intsngible fixe(l assets
Fixed asset investsnents
Current 8ss&ls
Creditors due within one yegr
Creditor5 over on8 year
6.332.201
6.332,201
6.129
581.305
1202.1531
121.5941
6,129
825,635
1322.2671
909,3001
244.330
1887,7061
Totsi Group
244,330
5,425.882
273,687
5.943,899
24 Operating lease commitments
At 30 November 2024 the company had commilTn8nts to make future minimum ￿ase payments under norFCarKel1ab￿ operaling18ases as
follows..
2024
2023
Amounts payabl•'.
Within one year
Within two and five year
Wlthin over five years
44.094
168,000
10.500
44.513
170,094
52.500
222.594
267.107
25 Rolat8d partlè8
Trustees are able lo make use of the accommodation al the National Centre when attending on business aThl usually provide a donation in
respect of this. No Trustees were provided 8ny nights ￿tr￿mo￿all0￿ In the year12023'. Nlll.
There are no transact￿nS wlh trustee5 orolher related parties olher than those disclosed a5 required bythe SORP elsewhe￿ in the financKal
slalemenls.
26 P08t balance sh8ot évont
In J8nu8ry2025 the charity was nolthe(l of 8 legacy which Is estimated to be In the regi(x) of £230.000.These funds are expected lo be
received in the 2025 financial yèar.
42